Clinical Trial
doi: 10.1007/BF00421474.
[Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)]
[Article in
German]
- PMID: 1096219
- DOI: 10.1007/BF00421474
Item in Clipboard
Clinical Trial
[Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)]
[Article in
German]
Psychopharmacologia.
1975.
Abstract
In a double-blind study on 36 volunteers the effects of 250 mug/kg (--)delta-9-trans-tetrahydrocannabinol p.o. on objective and performance tests measuring psychoticism according to Eysenck were assessed. The hypothesis was tested that subjects treated with delta-9-THC differ from those receiving placebo in the same way as endogenous psychotics differ from normals. Confirmation was obtained in only 5 out of 19 variables. Four of these 5 variables may be considered as tests of concentration.
Similar articles
-
[Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].Pharmakopsychiatr Neuropsychopharmakol. 1977 Jan;10(1):10-4. doi: 10.1055/s-0028-1094512. Pharmakopsychiatr Neuropsychopharmakol. 1977. PMID: 329291 Clinical Trial. German.
-
Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.Clin Pharmacol Ther. 1976 Mar;19(3):300-9. doi: 10.1002/cpt1976193300. Clin Pharmacol Ther. 1976. PMID: 770048 Clinical Trial.
-
Effects of (-)delta 9-trans-tetrahydrocannabinol (delta 9-THC) on memory, attention and subjective state. A double blind study.Psychopharmacologia. 1973 Dec 20;33(4):369-76. doi: 10.1007/BF00437515. Psychopharmacologia. 1973. PMID: 4590954 Clinical Trial. No abstract available.
-
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.Neuropsychopharmacology. 2006 Dec;31(12):2748-57. doi: 10.1038/sj.npp.1301197. Epub 2006 Aug 23. Neuropsychopharmacology. 2006. PMID: 16936704 Clinical Trial.
-
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.J Anal Toxicol. 2005 Jul-Aug;29(5):327-38. doi: 10.1093/jat/29.5.327. J Anal Toxicol. 2005. PMID: 16105257 Clinical Trial.
Cited by
-
[Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)].Arch Psychiatr Nervenkr (1970). 1976 Dec 31;223(1):77-87. doi: 10.1007/BF00367455. Arch Psychiatr Nervenkr (1970). 1976. PMID: 1070948 Clinical Trial. German.